Developmental Psychopharmacology (R21) | Apply Online

Opportunity Summary:

The Developmental Psychopharmacology (R21) funding opportunity (PA 09 112) is a National Institutes of Health (NIH) discretionary grant program designed to support exploratory research on how psychotherapeutic and psychotropic medications affect the developing, immature brain. Its central emphasis is on clarifying the neurobiological impact of medications used to treat mental disorders in children, with a strong focus on mapping developmentally specific patterns of physiological and neurobiological response. In practical terms, the FOA is aiming to move beyond general statements that a drug is "safe" or "effective" in youth and instead encourage studies that identify when, how, and through what mechanisms responses differ across developmental stages, including sensitive periods where medication exposure could produce distinct short- or long-term effects.

The scientific scope is intentionally broad as long as it directly advances knowledge about developmental neurobiology in the context of pediatric psychopharmacology. Applications may propose research in model systems (including animal studies) as well as research in human populations, which allows investigators to combine mechanistic approaches (for example, developmental changes in receptor systems, neurotransmitter signaling, synaptic pruning, myelination, neuroendocrine function, or circuit maturation) with clinically relevant questions (for example, age-dependent variability in response, tolerability, or biomarker changes associated with commonly used pediatric psychiatric medications). The FOA is oriented toward understanding the developing brain as a moving target biologically, where the same agent could plausibly have different effects depending on timing, dose, exposure duration, and the developmental status of the neural systems involved.

This announcement uses the NIH Exploratory/Developmental Grant Award (R21) mechanism, which is commonly used for early-stage, proof-of-concept, or high-impact exploratory studies that may not yet have the extensive preliminary data expected of larger research project grants. The R21 structure fits work that is trying to establish feasibility, generate key mechanistic insights, develop or validate new approaches, or produce foundational datasets that can later support a more extensive research program. The FOA also notes that it runs in parallel with a companion announcement of the same scientific scope that uses the NIH R01 mechanism (PA 09 111), providing a pathway for projects that are ready for a more mature, longer-term research plan.

Funding decisions under PA 09 112 are contingent on the availability of funds and the submission of a sufficient number of meritorious applications, meaning there is no guaranteed number of awards and competition depends both on appropriations and on application quality. The opportunity is categorized under federal assistance areas that include Mental Health Research Grants (CFDA 93.242), Drug Abuse and Addiction Research Programs (CFDA 93.279), and Child Health and Human Development Extramural Research (CFDA 93.865), which signals that relevant projects may intersect mental health, substance use, and child development priorities across NIH institutes and centers.

Eligibility is expansive and includes a wide range of domestic and non-domestic entities. Eligible applicants include state, county, city, township, and special district governments; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (including 501(c)(3) and other nonprofit structures); for-profit organizations (including small businesses); independent school districts; public housing authorities and Indian housing authorities; and multiple categories of tribal governments and tribal organizations. The FOA explicitly includes a variety of institution types often highlighted by NIH for broad participation, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations. It also permits foreign organizations, regional organizations, and U.S. territories or possessions. There is no cost sharing or matching requirement, which reduces barriers for applicants who might otherwise need to provide non-federal funds.

Key timeline information in the source data indicates the opportunity was posted on February 25, 2009, with dates reflecting that it is now archived (archive date February 7, 2010). The original closing date is listed as January 7, 2012, while the current closing date shown is January 7, 2010, reflecting how NIH postings sometimes record multiple cycles and subsequent archiving. For applicants at the time, the authoritative details would have been in the full FOA text hosted on the NIH grants site, which is linked in the announcement.

For technical or access issues, the announcement directs users to contact the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV, which is typical for NIH postings when applicants have trouble retrieving the full FOA online. Overall, PA 09 112 targets a clear gap in pediatric mental health treatment research: understanding not only whether medications work in children, but how developing neurobiology shapes drug response, risk, and mechanism across childhood and adolescence, using approaches that can span from basic developmental neuroscience to translational and clinical investigation.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health Income Security and Social Services

Next opportunity: Developmental Psychopharmacology (R01)

Previous opportunity: University Centers for Excellence in Developmental Disabilities (UCEDDs)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 09 112

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 09 112) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 112", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.